Jonathan Leiken - Jan 29, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Signature
Jonathan B. Leiken
Stock symbol
DBD
Transactions as of
Jan 29, 2022
Transactions value $
-$110,607
Form type
4
Date filed
1/31/2022, 03:45 PM
Next filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability -$85.6K -9.72K -6.39% $8.80* 142K Jan 29, 2022 Direct F1, F2
transaction DBD Common Shares Tax liability -$25K -2.85K -2% $8.80* 139K Jan 30, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 21.4K Jan 29, 2022 Common Shares 21.4K $32.33 Direct F3
holding DBD Non-Qualified Stock Option 24.6K Jan 29, 2022 Common Shares 24.6K $27.39 Direct F3
holding DBD Non-Qualified Stock Options 46.9K Jan 29, 2022 Common Shares 46.9K $26.60 Direct F3
holding DBD Non-Qualified Stock Option 24.5K Jan 29, 2022 Common Shares 24.5K $18.75 Direct F4
holding DBD Non-Qualified Stock Option 43.7K Jan 29, 2022 Common Shares 43.7K $4.08 Direct F4
holding DBD Non-Qualified Stock Option 12K Jan 29, 2022 Common Shares 12K $11.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.